Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (31-40 of 342) with videos related to

Pageof 35
Sort By:
Future Oncology (London, England)|June 21, 2014
Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemiaJohn L Reagan, Jorge J Castillo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Not all aggressive adult T-cell leukemia/lymphoma subtypes are created equalJorge J Castillo, Brady E Beltran
Medicine and Health, Rhode Island|February 5, 2011
Management of HIV-associated lymphomasChia-Ching Wang, Jorge J Castillo
Expert Review of Anticancer Therapy|February 24, 2011
Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemiaJohn L Reagan, Jorge J Castillo
The Lancet. Haematology|July 1, 2018
The real world of Waldenström's macroglobulinaemiaSteven P Treon, Jorge J Castillo
Blood Advances|January 4, 2018
What should be the goal of therapy for Waldenström macroglobulinemia patients? Complete response should be the goal of therapySteven P Treon, Jorge J Castillo
Leukemia|October 9, 2019
What is new in the treatment of Waldenstrom macroglobulinemia?Jorge J Castillo, Steven P Treon
The Oncologist|May 24, 2012
Diagnosis and management of hyponatremia in cancer patientsJorge J Castillo, Marc Vincent, Eric Justice
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's LymphomaJorge J Castillo, Samir Dalia, Helen Shum
Hematology/Oncology Clinics of North America|June 24, 2019
Lymphoplasmacytic Lymphoma and Marginal Zone LymphomaLuis M Juárez-Salcedo, Jorge J Castillo
Pageof 35

Showing results (31-40 of 342) with videos related to

Sort By:
Pageof 35
Future Oncology (London, England)|June 21, 2014
Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemiaJohn L Reagan, Jorge J Castillo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Not all aggressive adult T-cell leukemia/lymphoma subtypes are created equalJorge J Castillo, Brady E Beltran
Medicine and Health, Rhode Island|February 5, 2011
Management of HIV-associated lymphomasChia-Ching Wang, Jorge J Castillo
Expert Review of Anticancer Therapy|February 24, 2011
Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemiaJohn L Reagan, Jorge J Castillo
The Lancet. Haematology|July 1, 2018
The real world of Waldenström's macroglobulinaemiaSteven P Treon, Jorge J Castillo
Blood Advances|January 4, 2018
What should be the goal of therapy for Waldenström macroglobulinemia patients? Complete response should be the goal of therapySteven P Treon, Jorge J Castillo
Leukemia|October 9, 2019
What is new in the treatment of Waldenstrom macroglobulinemia?Jorge J Castillo, Steven P Treon
The Oncologist|May 24, 2012
Diagnosis and management of hyponatremia in cancer patientsJorge J Castillo, Marc Vincent, Eric Justice
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's LymphomaJorge J Castillo, Samir Dalia, Helen Shum
Hematology/Oncology Clinics of North America|June 24, 2019
Lymphoplasmacytic Lymphoma and Marginal Zone LymphomaLuis M Juárez-Salcedo, Jorge J Castillo
Pageof 35